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Inhibition of NUCKS Facilitates 
Corneal Recovery Following Alkali 
Burn
Ming-Wai Poon1,2,3, Dan Jiang3, Peng Qin3, Yuelin Zhang3, Beiying Qiu4, Sumit Chanda5, 
Vinay Tergaonkar4, Qing Li3, Ian Y. Wong3, Zhendong Yu6, Hung-Fat Tse1, David S. H. Wong3 & 
Qizhou Lian1,2,3
Corneal wound healing involves a complex cascade of cytokine-controlled cellular events, including 
inflammatory and angiogenesis responses that are regulated by transcriptional chromatin remodeling. 
Nuclear Ubiquitous Casein and cyclin-dependent Kinase Substrate (NUCKS) is a key chromatin modifier 
and transcriptional regulator of metabolic signaling. In this study, we investigated the role of NUCKS 
in corneal wound healing by comparing its effects on corneal alkali burn in NUCKS knockout (NKO) 
and NUCKS wild-type (NWT) mice. Our data showed that following alkali-injury, inhibition of NUCKS 
(NKO) accelerated ocular resurfacing and suppressed neovascularization; the cytokine profile of alkali 
burned corneas in NKO mice showed suppressed expression of inflammation cytokines (IL1A & IL1B); 
upregulated expression of antiangiogenic factor (Pigment Epithelium-derived Factor; PEDF); and 
downregulated expression of angiogenic factor (Vascular Endothelial Growth Factor, VEGF); in vitro, 
following LPS-induced NFκB activation, NKO corneal cells showed reduced expression of IL6, IP10 and 
TNFα. In vitro, corneal epithelial cells showed reduced NF-κb activation on silencing of NUCKS and 
corresponding NFκB-mediated cytokine expression was reduced. Here, we illustrate that inhibition of 
NUCKS played a role in cytokine modulation and facilitated corneal recovery. This reveals a potential 
new effective strategy for ocular burn treatment.
Corneal wound healing is a process that involves various cellular activities that include inflammation, angiogene-
sis, migration and proliferation1,2, and that are regulated by cytokines (IL1A, IL1B, Vascular Endothelial Growth 
Factor, VEGFA, Pigment Epithelium-derived Factor, PEDF). Fine control of cytokine-mediated cellular events is 
important to minimise scarring and achieve optimal clinical recovery.
Recently, DNA binding proteins have been described in the feedback loop of the cytokine induced cascade2–6. 
A nuclear DNA binding protein, Nuclear Ubiquitous Casein and cyclin-dependent Kinase Substrate (NUCKS), 
which is widespread in vertebrates and expressed ubiquitously by almost all human cell types7, has been reported 
to be a key chromatin modifier and transcriptional regulator of a number of signaling pathways, including cell 
death, proliferation and movement8. It is also reported to regulate the chronic inflammatory response in met-
abolic syndrome9,10 and is thought to be involved in protection of a cell against undesirable factors11. Recent 
research has further suggested a potential role of NUCKS in stress responses leading to selective regulation of 
gene transcription12. These reports show that NUCKS shares many of the important functional properties which 
are important in modulation of corneal wound healing as well as an ability to precisely regulate the inflammatory 
response and cytokine release3. We therefore aimed to determine whether inhibition of NUCKS would facilitate 
corneal recovery with a particular focus on its role in cytokine modulation.
We investigated the role of NUCKS in corneal wound healing, focusing on the corresponding inflammatory 
and angiogenic responses in NUCKS knockout (NKO) and NUCKS wild-type (NWT) mice following central 
corneal alkali burn. Our results showed that compared with NWT, NKO mice exhibited faster corneal resurfac-
ing and suppressed angiogenic responses that was associated with fine modulation of cytokines: inflammatory 
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factors (IL1A and IL1B) and angiogenic factor (VEGF) and anti-angiogenic factor (PEDF). Our in vitro intra-
cellular data revealed that upon stimulation with lipopolysaccharide (LPS; LPS-induced-NFκ B activation), NKO 
group showed reduced expression on IL6, IP10 and TNFα compared with NWT group. In addition, silencing 
of NUCKS and stimulation with LPS resulted in reduced NFκ B signaling activation and reduced expression of 
cytokines downstream of the NFκ B pathway.
Results
Inhibition of NUCKS Accelerates Corneal Resurfacing Following Alkali Injury in Vivo. Genotypes 
of NWT and NKO mice were confirmed as described previously (Supplementary Figure S1)13. Alkaline injury 
was induced within a confined circular area ~2-mm in diameter in the central corneal region in NWT and NKO 
mice. The effects of inhibition of NUCKS on corneal wound healing following alkali injury were investigated. 
Bright field and fluorescein images of the corneal healing process were recorded at specific post injury time points 
(day 0, 3, 7 and 14) (Fig. 1). Using the slit lamp system, a slit beam illumination was generated for the examina-
tion of oedema and corneal opacity. Our bright field data showed that faster recovery was observed in the NKO 
group than the NWT group. On day 14, corneas of the NKO group were transparent whereas those of the NWT 
group still showed oedema (Fig. 1A, upper panel of NKO; no oedema; upper panel of NWT; ***severe oedema; 
*oedema). Green fluorescein staining was used in the slit lamp examination, corneal defeat stained green (the 
Figure 1. Inhibition of NUCKS Promotes Corneal Resurfacing in Alkali Injured Corneas in Vivo.  
(A) Bright field images (upper rows of NWT and NKO columns) and fluorescein images (lower rows of NWT 
and NKO columns) were captured by slit lamp biomicroscopy. Representative bright field images are shown for 
NWT (i, iii, vii, xi and xv) and NWT mice and (ii, v, ix, xiii, xvii) at specific time points (pre-injury, days 0, 3, 
7 and 14). NKO mice exhibited less severe oedema than NWT mice at the end point, day 14. (NWT*oedema, 
N = 4; NKO no oedema, N = 4; Scale bars: 2 mm). Representative fluorescein images are shown for NWT  
(iv, viii, xii and xvi) and NKO mice (vi, x, xiv and xviii). Corneal defeat recovery in NKO mice was significantly 
faster than that for NWT mice at the end point, post injury day 14. (B) Percentage of retained corneal defeat was 
calculated as follows: the area of defeat retained at a specific time point divided by the area of defeat measured 
on post injury day 0 (initial point following injury). On day 3, NWT mice showed 96.56 ± 3.89% and NKO mice 
27.75 ± 6.61% defeat, indicating that NKO mice achieved better initial healing. As early as day 7, NKO mice 
showed no defeats 0 ± 0% compared with NWT mice who showed 84.03 ± 9.67% defeat. At the end point on 
day 14, NWT mice retained 50.18 ± 7.05% defeat and NKO mice exhibited no defeats 0 ± 0%. (*P < 0.01; NWT 
N = 4; NKO N = 4; Scale bars: 2 mm).
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defeat at the time immediate after injury, day 0, was defined as 100%) (Fig. 1A). Corneal recovery was nota-
bly faster in the NKO group compared with the NWT group. NWT corneas showed positive staining (corneal 
defeats) on days 3, 7 and 14 (Fig. 1A, lower panel in NWT). In contrast, NKO corneas showed minimal staining 
on day 3 and no stain was found (stained negative) on day 7 (Fig. 1A, lower panel in NKO). The percentage of 
retained defeat for NWT and NKO mice respectively was 100 ± 0% and 100 ± 0% on day 0; 96.56 ± 3.89% and 
27.75 ± 6.61% on day 3; 84.03 ± 9.67% and 0 ± 0% % on day 7 and 50.18 ± 7.05% vs 0 ± 0% on day 14 (Fig. 1B; 
*P < 0.01; NKO vs NWT).
Inhibition of NUCKS Promotes Healing in Vitro. Corneal epithelial marker cytokeratin K3 (K3) and 
conjunctival epithelial cell marker cytokeratin K19 (K19) were used to confirm the identity of the cultures iso-
lated from the corneas of NWT and NKO groups. Our data showed that both cultures were positively stained for 
K3 (~100%), but negatively stained for K19 (Fig. 2A and B respectively), indicating that both of the isolated cell 
cultures were corneal epithelial cells.
To examine the effects of inhibition of NUCKS on cell migration, a classic scratch wound healing assay14 was 
performed. By scraping the cultures (NWT and NKO) with a 10 μ l pipette tip, a cell-free space was generated 
(Fig. 3A). Our data demonstrated faster wound closure in the NKO group. The percentage of wound retained 
for NWT and NKO mice respectively was 100 ± 0% and 100 ± 0% at 0 hour; 79.44% ± 3.5 and 66.75 ± 4.5% at 
8 hours; 74.80 ± 3.5% and 49.20 ± 2.8% at 12 hours and 58.82 ± 2.2% and 0.03 ± 0.5% at 24 hours (*P < 0.01; 
NKO vs NWT).
Inhibition of NUCKS Reduced the Expression of Inflammatory Cytokines, IL1A &IL1B, 
Following Alkali Injury in Vivo. Following corneal alkali injury, corneas were harvested at various time 
points from NWT and NKO groups. Since IL1 is a master gene that regulates inflammation and other diverse 
cellular responses in corneal recovery2 and the expression of IL1A and IL1B peaks at day 7 post alkali injury15,16, 
we chose to study IL1A and IL1B at day 7. Our data also showed full recovery of NKO corneas by day 14 that was 
consequently taken as the end-point in our cytokine study. The relative level of expression of NKO was calculated 
as follows: all the expression levels in NWT and NKO mice were normalized to the corresponding expression 
levels of GAPDH. The relative level of expression at a particular time point for NKO mice was taken as the ratio 
of expression in NKO mice compared with that in NWT mice at that particular time point. The baseline level 
pre-injury, which was around 1, indicated that expression in NKO mice was similar to that of NWT mice at the 
initial time point (normal condition without injury); on the contrary at subsequent time points a lower relative 
expression than baseline in NKO mice indicated downregulation of cytokine expression in NKO, and vice versa. 
Our data showed that in NKO mice. the expression of IL1A and IL1B was reduced (reduced by 3.33 fold and 2.34 
fold respectively for IL1A and IL1B; **P < 0.001) on day 7 compared to NWT mice. On day 14, the expression 
level of NKO for IL1A and IL1B returned to baseline level (Fig. 4A and B). Taken together, inhibition of NUCKS 
is associated with precise regulated expression of inflammatory cytokines, IL1A and IL1B, following injury.
Inhibition of NUCKS Reduced Angiogenic Response Following Alkali Injury in Vivo. The effect 
of NUCKS deletion on corneal neovascularization in vivo was analyzed. Alkali was administered to the central 
region of the corneas in NWT and NKO mice and the neovascularization process monitored for 14 days (at the 
time point: post injury days 0, 7, and 14). The total area of blood vessels was recorded and analyzed with software 
‘Image Processing and Analysis in Java’ (Image J; Wayne Rasband, National Institute of Mental Health, Bethesda, 
Maryland, USA) for both the NWT and NKO groups (Fig. 5A). Our data showed that a reduced corneal angi-
ogenic response was observed in the NKO group compared with the NWT group. In the NWT group, a greater 
response of corneal angiogenesis was observed on days 7 to 14; on the contrary in the NKO group corneal angi-
ogenesis was reduced on day 7 and gradually diminished on day 14 (Fig. 5A). The mean area of corneal neovas-
cularization for NWT and NKO mice was 1.017 ± 0.124 mm2 and 0.466 ± 0.125 mm2 respectively on day 7; and 
0.868 ± 0.066 mm2 and 0.341 ± 0.043 mm2 on day 14 (*P < 0.01; Fig. 5B).
Inhibition of NUCKS Downregulated Expression of Angiogenic VEGF and Upregulated 
Expression of Anti-Angiogenic Factors (PEDF) Following Alkali Injury in Vivo. We investigated the 
role of NKO in the angiogenic response of the cornea following alkali-burn by comparing the particular responses 
in NKO and NWT mice. Corneas were harvested at particular time points following injury, and RNA extracted, 
converted for cDNA and analyzed using real time RT-PCR. The expression of anti-angiogenic and angiogenic 
cytokines, PEDF and VEGF, respectively, was examined. As for our previous data in Fig. 1, NKO mice showed full 
recovery on day 14, thus day 14 was set as the end point. The relative level of expression by NKO mice was calcu-
lated as follows: all expression levels of NWT and NKO mice were normalized to the corresponding expression 
level of GAPDH. The relative level of expression at a particular time point for NKO mice was taken as the ratio 
of expression of NKO mice compared with that of NWT mice at that particular time point. The baseline level 
pre-injury, which was around 1, indicated that expression by NKO mice was similar to that of NWT mice at the 
initial time point (normal condition without injury); at subsequent time points, there was a lower relative expres-
sion by NKO mice compared with baseline indicating downregulation of cytokine expression. In NKO mice, 
mRNA expression of PEDF was upregulated (2.63 fold; **P < 0.001) in corneas on day 7, and returned to the basal 
level on day 14 (Fig. 6A) compared to NWT mice. In addition, the level of expression of VEGF remained the same 
as baseline on day 7 and was downregulated on day 14 (1.86 fold; **P < 0.001) in NKO mice corneas (Fig. 6B) 
compared to NWT mice. Our data demonstrate that inhibition of NUCKS precisely regulated the expression level 
of antiangiogenic and angiogenic factors to enable good recovery of injured corneas.
NUCKS regulates NF-κB Activation. The relationship between NFκ B and NUCKS was examined 
in vitro. Corneal epithelial cells were transfected with luciferase construct that reflects the cellular activities of the 
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corresponding signaling pathways. NUCKS-overexpressed cells, compared with null-overexpressed cells (con-
trol), showed enhanced NFκ B activities upon TNF activation (Fig. 7A). Similarly, overexpression of NUCKS also 
enhanced lipopolysaccharide (LPS)-induced NFκ B activation (Fig. 7Bi) and LPS-induced-interferon-stimulated 
Figure 2. Corneal Epithelial Cells Cultures Isolated from (A) NWT and (B) NKO mice were Positively Stained 
with Corneal Epithelial Specific Marker, Cytokeratin K3 on Immunofluorescence Staining. (A) Staining for 
NWT culture. (i) cytokeratin K3 (K3), (ii) DAPI, (iii) combination of K3 with DAPI. (iv) cytokeratin K19 (K19), 
(v) DAPI, (vi) combination of K19 with DAPI. NWT cell cultures were positively stained with K3 (i, ii, iii), and 
negatively stained with K19 (iv, v, vi) (NWT, N = 3; NKO, N = 3. (B) Staining for NKO culture. (i) K3, (ii) DAPI, 
(iii) combined K3 and DAPI. (iv) K19, (v) DAPI, (vi) combined K19 with DAPI. NKO mice cell cultures were 
positively stained with K3 (i, ii, iii) and negatively stained with K19 (iv, v, vi) (NWT, N = 3; NKO, N = 3). Our 
data confirmed that the isolated cultures from NWT and NKO mice were (~100% K3-positive) pure corneal 
epithelial cells.
www.nature.com/scientificreports/
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Figure 3. Inhibition of NUCKS Facilities Healing in the Classic Scratched Wound in Vitro. Scratched 
cultures of cells from NWT and NKO mice were monitored for 24 hours and the process was recorded at 
specific time points (0 hr, 8 hrs, 12 hrs and 24 hrs) under microscopy. (A) Representative images were captured 
and are presented for: (i, iii, v, vii) NWT group and (ii, iv, vi, viii) NKO group at particular time points: 0, 8, 
12, and 24 hours. NKO group showed faster wound healing than the NWT group and recovery at 24 hours 
(NWT, N = 3; NKO, N = 3). Scale bars: 200 μ m. (B) Graphic representation of the data. NWT group showed 
58.82 ± 2.20% retention, while NKO group showed 0.03 ± 0.50% retention after 24 hours. (*P < 0.01; NWT, 
N = 3; NKO, N = 3).
Figure 4. Inhibition of NUCKS Resulted in Reduced Expression of the Key Inflammatory Cytokines, (A) 
IL1A and (B) IL1B. Corneas were harvested from NWT and NKO mice at particular time points. The level of 
expression of IL1A (3.33-fold reduction; **P < 0.001) and IL1B (2.34- fold reduction; **P < 0.001) was reduced 
in the NKO group on day 7. Level of IL1A and IL1B returned to baseline on by day 14 (NWT N = 12; NKO 
N = 12).
www.nature.com/scientificreports/
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response element (ISRE) activation (Fig. 7Bii). Upon Poly-inosinic-cytidylic (polyIC) treatment, NFκ B activation 
(Fig. 7Ci) and ISRE activation (Fig. 7Cii) were also enhanced by overexpressing NUCKS. On the contrary, we 
demonstrated that silencing of NUCKS along with the stimulation of LPS reduced expression of TNFα (Fig. 7Di), 
IL8 (Fig. 7Dii) and MCP1 (Fig. 7Diii). We also found that upon silencing of NUCKS and LPS stimulation, the 
phosphorylation of IKK, p65 proteins and Iκ Bα (PIκ B; a key for the activation NFκ B cascade) was impaired 45 
mins post- LPS stimulation until the end point of 120 minutes (Fig. 7E). With the above data, we demonstrated 
that NUCKS regulated NFκ B and ISRE activation, the expression of the particular NFκ B-mediated cytokines and 
the phosphorylation of particular proteins critical for the signaling pathway in ocular epithelial cells.
LPS-induced-NFκB-Activation of NKO Corneal Epithelial Cells Showed Reduced Expression of 
Phosphorylated IκB (P IκB), IL6, IP10 and TNFα. We further tested the effects of inhibition of NUCKS 
and LPS-induced NFκ B activation on corneal epithelial cells isolated from NWT and NKO mice in vitro. The 
expression of phosphorylated Iκ B and various inflammatory cytokines was investigated. Upon LPS induction, 
NKO mice showed reduced expression of PIκ B compared with NWT mice. To confirm the validity of the results 
shown in Fig. 8Ai and ii, a control experiment was performed with the NFκ B inhibitor, SC154, and corneal epi-
thelial cells in vitro. Expression of PIκ B and TNFα (Fig. 8Bi–iii) was tested on LPS-treated or LPS + SC154 treated 
corneal epithelial cells. The NKO mice showed similar effects with the NFκ B inhibitor, SC-154, demonstrating 
reduced expression of PIκ B and TNFα . Next, we investigated the effects of inhibition of NKO on expression of 
inflammatory cytokines (IL-6, IL-10, INFγ , IP10, TNFα and IL-12), upon LPS-induced NFκ B activation. The 
NKO group showed reduced expression of various pro-inflammatory cytokines (IL617, IP1018 and TNFα 19) com-
pared with the NWT group (Fig. 8Ci and ii). (Full-length western blot images are presented in Supplementary 
Figure S2).
Discussion
Cellular events, such as cell movement, apoptosis and cell proliferation, followed by scar formation are critical to 
the corneal recovery process1,2. Each specific cellular check-point in the recovery process is precisely maintained 
by a balance of the specific cytokines that are expressed in a timely manner and facilitate the delicate process 
of corneal healing2. Among the various pathways involved in controlling cytokine regulation, the NFκ B sign-
aling pathway is widely recognized and studied. NFκ B is a principal transcription factor that controls various 
Figure 5. Inhibition of NUCKS Resulted in a Reduced Angiogenic Response in Vivo. (A) Representative 
(dorsal and lateral) corneal neovascularization photographs at specific time points (post injury day 0, 7, and 14)  
of (i, ii, v, vi, ix and x) NWT and (iii, iv, vii, viii, xi and xii) NKO groups are shown. NKO group showed less 
severe angiogenic response compared with NWT group on day 7 and day 14 (neovascularization marked by 
arrows; Scale bars: 2 mm). (B) Graphic representation of the mean total area of neovascularization. ImageJ was 
used for the analysis. Compared with NWT, NKO mice exhibited a notable reduction in angiogenic response 
on day 7 (NWT and NKO; 1.017 ± 0.124 mm2 and 0.466 ± 0.125 mm2; *P < 0.01) and day 14 (NWT and NKO; 
0.868 ± 0.066 mm2 and 0.341 ± 0.043 mm2; *P < 0.01) (NWT, N = 4; NKO, N = 4).
www.nature.com/scientificreports/
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biological processes, including corneal wound healing, inflammation20, angiogenesis, apoptosis and the stress 
response21–25. NFκ B is also thought to be involved in several ocular surface disorders, including chemical injury, 
microbial infections, dry eye, pterygium, ultraviolet radiation-induced injury and corneal graft rejection26. We 
have reported previously that a regulator of NFκ B, RAP14,27, plays a role in angiogenesis and the inflammatory 
response28 and corneal recovery is enhanced via deletion of RAP1. Recently, genome-wide ChIP sequencing 
proved that NUCKS could bind more than 1000 genes involved in inflammation12. It is possible that NUCKS, as 
a transcription factor, is involved in the regulation of NFκ B activation, the release of NFκ B-mediated-cytokine 
and the particular cellular events driven by these particular cytokines for inflammation and angiogenesis, thus 
resulting in an optimal clinical recovery of burnt corneas29,30.
Our data demonstrated in vivo that deletion of NUCKS facilitated corneal resurfacing and reduced angio-
genic responses following alkali burn. Furthermore, we showed that inhibition of NUCKS in vivo modulated 
inflammatory and angiogenic cytokines during the wound healing process. On LPS-induced NFκ B activation of 
isolated corneal epithelial cells from NWT and NKO mice, NKO mice showed reduced expression of PIκ B and 
inflammatory cytokines in vitro compared with the NWT group. Upon either stimulation of TNF, LPS or polyIC, 
overexpression of NUCKS enhanced NFκ B and ISRE activation, whereas silencing of NUCKS reduced expression 
of NFκ B- mediated cytokines (TNF, IL8, MCP1) and reduced the phosphorylation of IKK2, P65 and Iκ Bα in vitro 
in corneal epithelial cells. Others have reported that NUCKS is a key chromatin modifier and transcriptional reg-
ulator of a number of signaling pathways and is involved in regulation of chronic inflammation in metabolic syn-
drome9,10. NUCKS also plays a role in cell protection against undesirable factors31 and cell proliferation, apoptosis 
and cell movement8. In this study, our data provided further evidence that NUCKS enhanced NFκ B activation, 
and modulated the expression of NFκ B-mediated cytokines, regulated NFκ B-mediated phosphorylation of IKK2, 
P65 and Iκ Bα and modulated the various specific inflammatory and angiogenic cytokines.
In our model of alkali injury in NKO mice, expression of the inflammatory cytokines, IL1A and IL1B was 
downregulated. IL1A is the master gene in wound healing and released first for epithelialization and in response 
to inflammation1,32. Meanwhile IL1B plays a role in various cellular events such as fibrosis, cell proliferation, 
apoptosis, and differentiation33,34. Our data on the downregulation of these inflammatory cytokines, IL1A and 
IL1B, were shown to follow the fine healing process in vivo. Similar mechanisms of precise regulation of inflam-
matory cytokines in good recovery have also been reported previously35,36.
Angiogenesis is another crucial factor during the healing process. The fine balance of angiogenic and 
anti-angiogenic cytokines (eg. VEGF and PEDF) is important for the survival, apoptosis of corneal endothelial 
cells2,5,6. In our study, PEDF was highly upregulated on day 7 and returned to baseline on day 14; expression of 
VEGF was repressed on day 14. A synchronized expression pattern was demonstrated during the healing process 
in the NKO group in vivo. Our data demonstrated a precise regulation of the expression of specific inflamma-
tory and angiogenic cytokines in the corneal recovery process following inhibition of NUCKS. This is consistent 
with our previous report on RAP1, a NFκ B regulator, that controls cytokine homeostasis and that is critical 
Figure 6. Inhibition of NUCKS Resulted in Reduced Expression of Antiangiogenic and Angiogenic Cytokines, 
(A) PEDF and (B) VEGF. Following injury corneas were harvested from NWT and NKO mice at particular 
time points. Compared with NWT mice, the relative expression level of PEDF (~2.63-fold, **P < 0.001) was 
upregulated in NKO mice on day 7 and returned to normal on day 14. Furthermore, the relative expression level 
of VEGF was downregulated (~1.86-fold, **P < 0.001) in NKO mice on day 14 (NWT, N = 12; NKO, N = 12).
www.nature.com/scientificreports/
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for fine control of various cellular events in corneal healing28. Here, our data showed a similar mechanism of 
cytokine-modulated recovery by controlled activation of NFκ B, similar to previous findings4,28,35,36.
In summary, this is a first study to describe the role of NUCKS in corneal wound healing, inflammation and 
angiogenesis and links NUCKS to the activation of NF-κ B and modulation of various cytokines. Our findings 
shed light on NUCKS (silencing of NUCKS) as a new therapeutic target for fine recovery of the injured cornea.
Materials and Methods
The Transgenic Mouse Lines NWT and NKO. All animal experiments were performed in accordance 
with relevant guidelines and regulations by the University of Hong Kong and approved by the Committee on 
the Use of Live Animals in Teaching and Research’ (CULATR) (Approval ID: 2533–11). The transgenic mouse 
lines (NWT and NKO) were gifts from Dr Vinay Tergaonkar (IMCB), the Laboratory of NFκ B Signaling, 
Singapore13. Genotypes of all NWT and NKO mice were confirmed (full-length gel image is presented in 
Supplementary Figure S1) (primary antibody: anti-NUCKS antibody; Abcam 1:200; corresponding secondary 
antibody: Cell Signaling, 1:1000).
Figure 7. NUCKS regulates NFκB Activation in in Vitro Studies. Cells were transfected with luciferase 
reporter and the corresponding luciferase activity represented intracellular NFκ B/ISRE activity. Next, the 
NUCKS expressing construct (NUCKS) or empty vector (Control) was transfected to the cells, followed by 
(A) TNFα treatment or no treatment ( UT); NFκ B activation was measured (B) lipopolysaccharide (LPS) or 
no treatment ( UT); (i) NFκ B activation was measured and (ii) interferon stimulated response element (ISRE) 
activation was measured. (C) Poly-inosinic-cytidylic (polyIC) treatment or no treatment (UT); (i) NFκ B 
activation was measured and (ii) interferon stimulated response element (ISRE) activation was measured.  
(D) On NUCKS silencing and LPS-induced-NFκ B activation, the level of expression of (i) TNFα , (ii) IL8 and 
(iii) MCP1 was tested. (E) On NUCKS silencing and LPS-induced-NFκ B activation, protein expression level of 
the phosphorylated form of IKK, P65 and Iκ Bα was analyzed.
www.nature.com/scientificreports/
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Induction of Central Corneal Alkali Injury on Corneas of NWT and NKO Mice (in Vivo). After 
general anaesthesia, 3 μ L of 1 N sodium hydroxide solution was applied to the corneas (confined to a circular area 
~2-mm in diameter at the central corneal region) of adult NWT (N = 41) and NKO (N = 41) mice28.
Figure 8. NKO Corneal Epithelial Cells upon LPS-induced-NFκB-Activation Showed Reduced Expression 
of Phosphorylated IκB (P IκB), IL6, IP10 and TNFα Compared to NWT Group. (A) (i) Corneal epithelial 
cells isolated from NWT and NKO mice were treated with LPS in vitro; expression of PIκ B was measured (ii) 
Graphic representation for PIκ B data in (i) is shown. (B) (i) Corneal epithelial cells were treated with LPS or 
LPS + NFκ B inhibitor, SC 154. Expression of PIκ B and TNFα was tested. (ii and iii) Graphic representation 
of the relative expression of (ii) PIκ B and (iii) TNFα , respectively in (i) is shown. (C) On treatment with LPS, 
expression of various inflammatory cytokines (IL6, IL10, INFγ , IP10, TNFα and IL12) was compared and 
analyzed by flow cytometry analysis. Results for (i) NWT group and (ii) NKO group are shown.
www.nature.com/scientificreports/
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Corneal Resurfacing Following Alkali Injury in NWT and NKO Mice (in Vivo). 
(1) Examination of the degree of oedema and opacity on corneal healing was performed using a slit lamp (Cata-
logue number: KJ5D II, LANLING, KangJie Medical Co., Ltd.). Bright view images were recorded at specific 
time points (pre injury, post injury days 0, 3, 7 and 14).
(2) Investigation of the process of corneal resurfacing on corneal healing was performed with fluorescein stain 
(Fluorescein sodium ophthalmic strips, register number: HK49096, Contacare Ophthalmics and Diagnostics, 
Mfg. Lic. No. G/1197) and a slit lamp system. Fluorescein-stained corneal surface defeats were green upon 
excitation. Fluorescein images were recorded at particular time points (pre injury, post injury days 0, 3, 7 and 
14) (NWT, N = 4; N; NKO, N = 4).
(3) Investigation of the molecular role of NUCKS in the inflammatory response was performed with real time 
RT-PCR on isolated RNA from corneas of NWT and NKO mice at particular time points (before injury, days 
7 and 14; NWT, N = 12; N; NKO, N = 12). Key inflammatory cytokines IL1A and ILB were studied.
Corneal Angiogenic Response Following Alkali Injury in NWT and NKO Mice (in Vivo). 
(1) To investigate the degree of angiogenic response in corneal healing, bright view microphotography was per-
formed (NikonSM2800) (Chinetek Scientific Cat No. Infinity 1–3C)28. Bright view images were recorded at 
specific time points (days 0, 7 and 14) (NWT, N = 4; N; NKO, N = 4);
(2) To understand the molecular role of NUCKS in the angiogenic response in vivo, corneas were harvested 
at particular time points (baseline, post-injury days 7 and 14; NWT, N = 12; N; NKO, N = 12) and total 
RNA extracted and analyzed with real-time RT-PCR for key angiogenic (VEGF) and anti-angiogenic (PEDF) 
cytokines.
Total RNA Extraction, Reverse Transcriptase Reaction (RT-reaction) and Real-time Reverse 
Transcriptase -Polymerase Chain Reactions (real-time RT-PCR). Total RNA was extracted using 
a traditional method by trizol (RNAiso Plus (Cat. No. H9108B, TaKaRa) and converted to cDNA (Cat. No. 
RR047A, TaKaRa). Real-time RT PCR was performed with CYBR green and a real-time RT-PCR system (Cat. 
No. HRR820 A, TaKaRa; StepOnePlus™ Real-Time PCR Systems; Thermofisher) according to the manufacturer’s 
instructions. Specific primers (Supplementary Table 1) were used for the analysis28 (NWT; N = 24; NKO; N = 24).
Primary Cultures of Corneal Epithelial Cells Isolated from NWT and NKO Mice for in Vitro 
Study. The limbus region on the cornea was retained for the growth of epithelial cells. After harvesting, 
the corneas were cut into 1 mm2 sections and cultured on a thin film of SHEM medium [SHEM formulation: 
DMEM/F12 (Cat. No. Hyclone SH30023.01) FBS (Cat. No. 16000–044, Life Technologies) 5% HEPES (Cat. No. 
151630–080, GIBCO) Insulin-Transferrin-Selenium (ITS; 100× ) (1%) (Cat. No. 51500–056, GIBCO); (100× ) 
Hydrocortisone (0.5 μ g/ml) (Cat. No. 0025012ID, Life Technologies); Dimethyl sulfoxide (DMSO; 0.5%) (Cat. 
No. 67685, Sigma); and EGF (2 ng/ml) (Cat. No. PHG0311, Life Technologies)]. After 24–72 hrs, a monolayer 
of corneal epithelial cells would spread out from the sections. SHEM medium was replaced with Keratinocyte 
Serum-Free Medium (KSFM; Cat. No. 17005–042, Life Technologies; formation as described in manufacturer’s 
protocol). SHEM and KSFM was applied on alternate days to the cultures, and a monolayer culture was main-
tained for downstream assays28. (NWT, N = 3; NKO, N = 3).
The Identity of Corneal Epithelial Cells of the Isolated Cultures from NWT and NKO Was Confirmed 
by Immunofluorescence. Immunofluorescence staining using cytokeratin K3 (a specific marker of cor-
neal epithelial cells; Santa Cruz Cat No. SC-49179; 1:200) and cytokeratin K19 (a specific marker of conjunctival 
epithelial cells; Santa Cruz Cat No. Sc56371; 1:200) together with the corresponding secondary antibodies (Cell 
Signaling Technology; 1:1000) was performed to identify the isolated cell cultures from NWT and NKO mice28. 
A LEICA DMI6000B microscope (Leica Microsystems GmbH) was used for imaging (NWT, N = 3; N; NKO, 
N = 3).
Classic Wound Healing Scratch Assay in Vitro. Classic wound healing scratch assay14,28,37 was per-
formed by scraping the culture with a sterile 10 μ l pipette tip (Tip One, USA, Scientific Ocala, FL) on a confluent 
monolayer culture. Wound recovery was recorded at particular time points (0, 8, 12 and 24 hrs) with a light 
microscope (Nikon Eclipse TS100-F, Nikon, Japan.) and images were captured using a digital Camera (Nikon 
Digital Camera D70S, Nikon, Japan.). Scratch assay was performed on NWT and NKO corneal epithelial cultures 
(NWT, N = 3; N; NKO, N = 3).
Role of NUCKS in NFκB Activity and Modulation of Cytokines in Vitro. NUCKS (1 ug; Promega) 
pISRE-Luc (0.3 μ g; Strategene) and Renilla luciferase construct (0.2 μ g; Promega) were transfected with 
Lipofectamine 2000 (Invitrogen) and siRNA(50 nM; Dharmacon and Qiagen) with RNAiMax (Invitrogen). Cells 
were stimulated with the indicated ligands 24 hours post-transfection and assayed for luciferase activity at par-
ticular time points following stimulation by Dual-luciferase reagent (Promega) according to the manufacturer’s 
instructions.
Flow Cytometry Analysis of the Expression of Cytokines in Corneal Epithelial Cells Isolated from 
NWT and NKO Mice in Vitro. After 2 hrs of incubation with LPS, corneal epithelial cells were harvested 
and analyzed with flow cytometry to determine the expression of various cytokines using PE- conjugated or 
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APC- conjugated specific antibodies against IL6, IL10,IP10, INFγ , TNFα and IL12 (BD Biosciences. San Diego, 
CA), and isotype-matched immunoglobulins (as negative controls; BD Biosciences). BD FACSCalibur flow 
cytometry (BD Biosciences, NJ) was performed in accordance with the manufacturer’s instructions. (N = 5). 
Briefly, corneal epithelial cells in culture were detached using Accutase® Solution (Sigma Cat. No. A6964), then 
washed with sorting buffer (PBS with 1% FBS/BSA and 2 mM EDTA, keep 4 °C). Cells (106–107) were fixed, 
washed, resuspended again in 100 ul sorting buffer and incubated for 15 mins at room temperature with specific 
antibodies. Cells were then washed twice with sorting buffer and suspended (cell density = 106 cells/ml) for flow 
cytometry analysis38.
Western Blotting Analysis of Expression of PIκb and TNFα. To investigate the response of 
LPS-induced activation of NFκ B in corneal epithelial cells; we incubated corneal cells (NWT and NKO) with 
LPS for 0 and 15 mins. Cells were then harvested for Western Blotting analysis39 using specific antibodies for PIκ 
b (abcam). The housekeeping gene β -actin was used for normalization (abcam).
To investigate the response of LPS-induced activation of NFκ B to treatment with a NFκ B inhibitor SC-154, 
NWT mice corneal cells were incubated with (i) LPS or (ii) LPS combined SC-154, respectively for 15 mins and 
cells were harvested for Western Blotting analysis. Specific antibodies for PIκ b and TNFα (1:1000 abcam) were 
used. The housekeeping gene β -actin was used for normalization (abcam). Specific secondary antibodies (1:1000; 
Dako, USA)39,40 were used. Intensity of the bands was quantified using the Image Processing and Analysis in Java 
(Image J) software (Wayne Rasband.Research Services Branch, National Institute of Mental Health, Bethesda, 
Maryland, USA).
Statistical Analysis. The mean value of the samples belonging to either NWT or NKO groups are pre-
sented ± SD; unpaired student’s t-test was used to determine whether a difference existed between two groups. 
P-values ≤ 0.05 were considered statistically significant. The tests were two-tailed. Standard deviation (± s.d.) was 
applied for the error bars.
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